512 related articles for article (PubMed ID: 36686771)
1. Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma.
Xu Y; Hao X; Ren Y; Xu Q; Liu X; Song S; Wang Y
Front Oncol; 2022; 12():1063423. PubMed ID: 36686771
[TBL] [Abstract][Full Text] [Related]
2. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
Chen L; Huang L; Gu Y; Cang W; Sun P; Xiang Y
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233246
[TBL] [Abstract][Full Text] [Related]
3. Lactate: The Mediator of Metabolism and Immunosuppression.
Zhang Y; Zhai Z; Duan J; Wang X; Zhong J; Wu L; Li A; Cao M; Wu Y; Shi H; Zhong J; Guo Z
Front Endocrinol (Lausanne); 2022; 13():901495. PubMed ID: 35757394
[TBL] [Abstract][Full Text] [Related]
4. The crosstalking of lactate-Histone lactylation and tumor.
Rong Y; Dong F; Zhang G; Tang M; Zhao X; Zhang Y; Tao P; Cai H
Proteomics Clin Appl; 2023 Sep; 17(5):e2200102. PubMed ID: 36853081
[TBL] [Abstract][Full Text] [Related]
5. Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors.
Naik A; Decock J
Front Oncol; 2020; 10():598626. PubMed ID: 33324565
[TBL] [Abstract][Full Text] [Related]
6. Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells.
Zhang Q; Liu J; Lin H; Lin B; Zhu M; Li M
Explor Target Antitumor Ther; 2023; 4(3):519-536. PubMed ID: 37455832
[TBL] [Abstract][Full Text] [Related]
7. Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination.
Wang JH; Mao L; Wang J; Zhang X; Wu M; Wen Q; Yu SC
Cell Oncol (Dordr); 2023 Jun; 46(3):465-480. PubMed ID: 36656507
[TBL] [Abstract][Full Text] [Related]
8. Histone lactylation: from tumor lactate metabolism to epigenetic regulation.
Yu X; Yang J; Xu J; Pan H; Wang W; Yu X; Shi S
Int J Biol Sci; 2024; 20(5):1833-1854. PubMed ID: 38481814
[TBL] [Abstract][Full Text] [Related]
9. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
Zhao C; Wang B; Liu E; Zhang Z
Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
[TBL] [Abstract][Full Text] [Related]
10. Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects.
Chen AN; Luo Y; Yang YH; Fu JT; Geng XM; Shi JP; Yang J
Front Immunol; 2021; 12():688910. PubMed ID: 34177945
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma Development.
Serra M; Di Matteo M; Serneels J; Pal R; Cafarello ST; Lanza M; Sanchez-Martin C; Evert M; Castegna A; Calvisi DF; Mazzone M; Columbano A
Cell Mol Gastroenterol Hepatol; 2022; 14(3):609-624. PubMed ID: 35714859
[TBL] [Abstract][Full Text] [Related]
12. Role of lactate and lactate metabolism in liver diseases (Review).
Yao S; Chai H; Tao T; Zhang L; Yang X; Li X; Yi Z; Wang Y; An J; Wen G; Jin H; Tuo B
Int J Mol Med; 2024 Jul; 54(1):. PubMed ID: 38785162
[TBL] [Abstract][Full Text] [Related]
13. Histone lactylation regulates cancer progression by reshaping the tumor microenvironment.
Qu J; Li P; Sun Z
Front Immunol; 2023; 14():1284344. PubMed ID: 37965331
[TBL] [Abstract][Full Text] [Related]
14. Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy.
Feng XC; Liu FC; Chen WY; Du J; Liu H
World J Gastrointest Oncol; 2023 Apr; 15(4):617-631. PubMed ID: 37123054
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma.
Li Y; Mo H; Jia S; Wang J; Ma Y; Liu X; Tu K
Front Immunol; 2022; 13():1066773. PubMed ID: 36582227
[TBL] [Abstract][Full Text] [Related]
16. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics analysis to identify lung squamous carcinoma lactate metabolism-related subtypes and establish related index to predict prognosis and guide immunotherapy.
Wang C; Lu T; Xu R; Luo S; Zhao J; Zhang L
Comput Struct Biotechnol J; 2022; 20():4756-4770. PubMed ID: 36147667
[TBL] [Abstract][Full Text] [Related]
18. Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches.
de la Cruz-López KG; Castro-Muñoz LJ; Reyes-Hernández DO; García-Carrancá A; Manzo-Merino J
Front Oncol; 2019; 9():1143. PubMed ID: 31737570
[TBL] [Abstract][Full Text] [Related]
19. Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer.
Wang T; Ye Z; Li Z; Jing DS; Fan GX; Liu MQ; Zhuo QF; Ji SR; Yu XJ; Xu XW; Qin Y
Cell Prolif; 2023 Oct; 56(10):e13478. PubMed ID: 37060186
[TBL] [Abstract][Full Text] [Related]
20. A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma.
Li Y; Mo H; Wu S; Liu X; Tu K
Front Cell Dev Biol; 2021; 9():801959. PubMed ID: 35047511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
